Adam Zalewski - Concepedia

Author

Adam Zalewski

Also Known As

A A Zalewski, A ZALEWSKI, A Zalewski, A. A. Zalewski, A. Zalewski, A.A. Zalewski, Adam Zalewski, Andrew Zalewski, L. F. Zang, Zalewski, Adam

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Novartis (Switzerland)University of Basel Novartis Institutes for BioMedical Research KU Leuven

About

Adam Zalewski is an author at Boehringer Ingelheim (Germany) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	589
2	Engineering	6	6	258
3	Natural Sciences	2	2	73
4	Public Health	2	2	133
5	Health Sciences	1	1	96

Adam Zalewski

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Yi Shi, Ali Fard, A Galeo, Circulation	1994	238
Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. Yi Shi, Howard G. Hutchinson, David J. Hall, Circulation	1993	117
Changes in the basement membrane zone components during skeletal muscle fiber degeneration and regeneration. Adarsh K. Gulati, A. Hari Reddi, Adam Zalewski The Journal of Cell Biology Muscle FunctionCytoskeletonMechanotransductionCellular PhysiologyRegenerative Medicine	1983	96
MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information Wouter Heyndrickx, Lewis Mervin, Tobias Morawietz, Journal of Chemical Information and Modeling EngineeringMachine LearningMachine Learning ToolFederated StructureData Science	2023	94
Myocardial protection during transient coronary artery occlusion in man: beneficial effects of regional beta-adrenergic blockade. Adam Zalewski, Steven H. Goldberg, John Dervan, Circulation Cardiovascular PharmacologyCoronary Artery DiseaseAcute Myocardial InfarctionInflation IiiPublic Health	1986	88
Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists Oliver Schwardt, Said Rabbani, Margrit Hartmann, Bioorganic & Medicinal Chemistry Medicinal ChemistryEngineeringMedicineDrug DiscoveryMannosyl Triazoles	2011	80
Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates. Adam Zalewski, Yi Shi, Donald Nardone, Circulation	1991	64
FimH Antagonists: Structure–Activity and Structure–Property Relationships for Biphenyl α‐<scp>D</scp>‐Mannopyranosides Lijuan Pang, Simon Kleeb, Katrin Lemme, ChemMedChem Bioorganic ChemistryPeptide ScienceAntimicrobial ChemotherapyMolecular PharmacologyStereoselective Synthesis	2012	60
Splitting chemical structure data sets for federated privacy-preserving machine learning Jaak Simm, Lina Humbeck, Adam Zalewski, Journal of Cheminformatics	2021	56
Myocardial protection via coronary sinus interventions: superior effects of arterialization compared with intermittent occlusion. Adam Zalewski, Steven H. Goldberg, Sonya Slysh, Circulation Right AtriumHeart FailureIntermittent OcclusionCoronary Artery DiseaseCoronary Arterial Occlusion	1985	45

Page 1